APP-based transgenic models: The PDAPP model

Keyphrases

• Active Immunization 16%
• Alzheimer's Disease 100%
• Alzheimer's Disease Patient 16%
• Astrocytosis 16%
• Attractive Model 16%
• Behavioral Deficits 16%
• Binding Protein 16%
• Biochemical Alterations 16%
• Cerebral Amyloid Angiopathy 16%
• Diagnostic Approach 16%
• Diffuse Plaques 16%
• Disease Process 16%
• Genetic Factors 16%
• Hippocampal Atrophy 16%
• Histological Alterations 16%
• Human Amyloid Precursor Protein 16%
• Metabolism 16%
• Microgliosis 16%
• Mouse Model 16%
• Neuritic Plaques 16%
• Neuronal Cell Death 16%
• Neuropathology 33%
• New Diagnostics 16%
• New Therapeutics 16%
• Overexpressing 16%
• Passive Immunization 16%
• PDAPP 100%
• Small Animal Model 16%
• Structural Alterations 16%
• Synaptic Remodeling 16%
• Tauopathy 16%
• Therapeutic Approaches 16%
• Transgenic Mice 16%
• Transgenic Mouse Model 100%

Neuroscience

• Alzheimer's Disease 100%
• Amyloid 16%
• Amyloid Precursor Protein 16%
• Cerebral Amyloid Angiopathy 16%
• Gliosis 16%
• In Vivo 16%
• Metabolic Pathway 16%
• Neuronal Cell Death 16%
• Protein Binding 16%
• Senile Plaque 16%
• Tauopathy 16%
• Treatment of Alzheimer's Disease 16%